...
首页> 外文期刊>RSC Advances >Nano-caged shikimate as a multi-site cross-linker of collagen for biomedical applications
【24h】

Nano-caged shikimate as a multi-site cross-linker of collagen for biomedical applications

机译:纳米笼草sh草酸酯作为生物医学应用中的胶原蛋白多位交联剂

获取原文
获取原文并翻译 | 示例

摘要

The present study evaluated the application of a nano-biotechnological intervention of nutraceutical shikimate for the development of a potential multi-site cross-linker with enhanced cross linking, antimicrobial and cell proliferative activities. The cross-linking and therapeutic properties of the nutraceutical shikimate were simultaneously utilized by caging them onto silver nanoparticles. The caging of shikimate on silver nanoparticles resulted in the cumulative expression of the physico-chemical properties of both silver nanoparticles and shikimate. We observed that in shikimic acid caged silver nanoparticle (SCS nanoparticle) cross-linked collagen, the viscosity and self-assembly process of collagen, along with its mechanical and thermal properties, were significantly improved when compared with native collagen. The three dimensional conformation of collagen was also retained after cross-linking with SCS nanoparticles. Cell viability with SCS nanoparticle cross-linked collagen was found to be enhanced, in comparison to collagen films cross-linked with shikimic acid and native collagen. SCS nanoparticlestabilized collagen possessed both cell proliferative and anti-microbial properties, which would make SCS nanoparticles a superior cross-linker of collagen. The results suggested a new strategy for cross-linking collagen and provide scope for alternative biocompatible interventions in the development of biomaterials.
机译:本研究评估了营养保健品sh草酸酯的纳米生物技术干预在开发具有增强的交联,抗菌和细胞增殖活性的潜在多位交联剂中的应用。营养保健sh草酸酯的交联和治疗特性可通过将其笼罩在银纳米颗粒上同时使用。 iki草酸酯在银纳米颗粒上的笼蔽导致银纳米颗粒和sh草酸酯两者的理化性质的累积表达。我们观察到,在iki草酸笼状银纳米颗粒(SCS纳米颗粒)交联的胶原蛋白中,与天然胶原蛋白相比,胶原蛋白的粘度和自组装过程以及其机械和热学性能得到了显着改善。与SCS纳米粒子交联后,胶原蛋白的三维构象也得以保留。与用sh草酸和天然胶原交联的胶原膜相比,发现使用SCS纳米颗粒交联的胶原的细胞活力得到增强。 SCS纳米颗粒稳定的胶原蛋白具有细胞增殖和抗微生物特性,这将使SCS纳米颗粒成为胶原蛋白的优良交联剂。结果提出了一种新的胶原蛋白交联策略,并为生物材料开发中的其他生物相容性干预措施提供了空间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号